An exclusive first look into the transition of Medical Cannabis by Shoppers as Avicanna takes over and launches MyMedi.ca
Category: javierhasseblog
Could This Novel Psychedelic Compound Treat Major Depressive Disorder? Clinical Trial Seeks To Find Out
Exclusive details on Cybin’s IND application with the FDA, a move that could make its CYB003 compound the first psilocybin analog to be evaluated in Phase 1/2a development.
Psychedelics Co. Silo Wellness To Acquire Dyscovry Science, Seeking To Leverage Its Govt. Partnerships
Exclusive details on Silo Wellness’ proposed acquisition of Dyscovry Science, a company that, unlike most of its peers in the psychedelics space, which focus on mental health issues, is targeting a physiological condition: irritable bowel syndrome.
Psychedelics In Davos? Jason Silva Explains What’s Happening During The World Economic Forum
As the world’s top political and financial leaders gather in Switzerland for the World Economic Forum’s flagship annual event, the biggest names in the psychedelics space will fly out to do the same.
Former Actavis Head Of M&A Joins Psychedelics Company As CEO
In an exclusive conversation, pharma veteran Doug Drysdale revealed he has joined psychedelics-focused life sciences company Cybin Corp. as CEO.
First-Of-Its-Kind Clinical Trial To Study Psychedelic Treatments For PTSD In Veterans
A new series of clinical trials will look into psilocybin for the treatment of posttraumatic stress disorder (PTSD) in veterans. It is believed to be the first of its kind.
University Of Toronto, Canadian Biotech Company Collaborate On Cannabinoid-Based COVID-19 Treatment
In an exclusive conversation, the company’s CEO shares details of the collaboration and says, “Given our combined expertise and proven track record, this new project is very real and has the potential to save lives.”
Psychedelics Company Lands Deal To Dispense Ketamine Treatment Through 1,000+ Pharmacies In Canada
Champignon Brands announced this week that it will be dispensing its ketamine treatment through “one of Canada’s leading retail pharmacy chains,” with a retail footprint of more than 1,000 locations.
